Bender Robert & Associates’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,496
| Closed | -$205K | – | 46 |
|
|
2024
Q4 | $205K | Buy |
+11,496
| New | +$205K | 0.05% | 41 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 43 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 39 |
|
|
2024
Q1 | – | Sell |
-24,059
| Closed | -$62.8K | – | 49 |
|
|
2023
Q4 | $62.8K | Hold |
24,059
| – | – | 0.02% | 49 |
|
|
2023
Q3 | $45K | Hold |
24,059
| – | – | 0.01% | 46 |
|
|
2023
Q2 | $60.4K | Buy |
24,059
+10,000
| +71% | +$25.1K | 0.02% | 49 |
|
|
2023
Q1 | $24.6K | Buy |
+14,059
| New | +$24.6K | 0.01% | 53 |
|
|
2022
Q4 | – | Sell |
-14,059
| Closed | -$17K | – | 51 |
|
|
2022
Q3 | $17K | Hold |
14,059
| – | – | 0.01% | 54 |
|
|
2022
Q2 | $14K | Buy |
+14,059
| New | +$14K | 0.01% | 55 |
|
|
2021
Q2 | – | Sell |
-14,059
| Closed | -$83K | – | 52 |
|
|
2021
Q1 | $83K | Buy |
+14,059
| New | +$83K | 0.03% | 56 |
|